Biochemistry · Skim version

Nucleotide Metabolism: Build It, Recycle It, or Pay in Uric Acid

About 1 min to skim · 3 figures · Rewritten on

Read the full lesson → Skim the whole course →

The guiding idea

Nucleotides are costly to build — Lesch-Nyhan lives where recycling breaks, and gout and allopurinol live at the uric-acid end.

Nucleotides are costly to build, so cells recycle much of what they have.

  1. Three words first: base, nucleoside, nucleotide

  2. Two doors in, one way out

    AI-generated illustration: a central gold pool of purine nucleotides (IMP, AMP, GMP) on a loop. Freed bases leave the pool, most return through the recycle door (HGPRT, APRT), and what salvage misses leaves as uric acid. A build door with a gate refills the pool; PRPP pushes the gate open and the full pool pushes it shut. Food purine bypasses the pool and joins the uric-acid exit. An inset shows 'built' equal to 'not recycled' at steady state.
    The purine pool as a loop: two doors in (recycle and build) and one way out (uric acid). Salvage returns a large share of freed bases; the gate on the build door is pushed open by PRPP and shut by finished nucleotides, so at steady state the cell builds what it fails to recycle. Food purine mostly goes straight to the exit. AI-generated illustration
  3. The way out: uric acid

  4. When recycling breaks: Lesch-Nyhan syndrome

    AI-generated illustration: two copies of the purine loop side by side. With HGPRT working, freed bases return to the pool through the recycle door, the build gate is half open with one PRPP block, and a thin arrow leads to a small uric acid block. With HGPRT lost, the recycle door is crossed out, freed bases go down a thick arrow to a large uric acid block, three PRPP blocks pile up and the build gate is wide open with a thicker arrow into the pool. A separate box notes that the brain disease is not caused by urate.
    Lesch-Nyhan on the loop. Without HGPRT, freed hypoxanthine and guanine go to the exit, and the PRPP that salvage would have spent pushes the build gate open, so the extra purine leaves as uric acid too. The neurological disease is a separate harm whose mechanism is not fully understood. AI-generated illustration
  5. Pyrimidines: ring first

  6. DNA’s building blocks

  7. Counterfeits at each door

    AI-generated illustration: the folate cycle as a loop. THF is used by thymidylate synthase, which turns dUMP into dTMP for DNA copying and leaves the folate as DHF; DHFR turns DHF back into THF. A second arrow from THF feeds two carbons to the purine ring. Methotrexate blocks DHFR and FdUMP (from 5-fluorouracil) blocks thymidylate synthase, so either drug starves the cell of dTMP.
    The folate cycle behind two cancer drugs. Thymidylate synthase uses a folate carbon to turn dUMP into dTMP and leaves the folate as DHF; DHFR must recycle DHF to THF before it can carry another carbon, to thymidylate or to the purine ring. Methotrexate jams DHFR, starving both; FdUMP, made from 5-fluorouracil, traps thymidylate synthase. Either way the cell runs short of the dTMP it needs to copy its DNA. AI-generated illustration
  8. Going deeper

Read the full lesson → Skim the whole course →